Colloidal silver therapy Clinical Trials

• Study Comparing the DOVER Silver Foley Catheter to a Standard of Care Catheter and a Marketed Silver Coated Foley Catheter
  ClinicalTrials.gov Identifier: NCT00203515 - Active, not recruiting
  Urinary Tract Infections
  
• Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00400348 - Active, not recruiting
  Ovarian Cancer
  
• TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00356980 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS)
  ClinicalTrials.gov Identifier: NCT00482547 - Recruiting
  Catheterization
  
• Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
  ClinicalTrials.gov Identifier: NCT00003548 - Active, not recruiting
  Gastrointestinal Cancer; Pancreatic Cancer; Liver Cancer; Female Reproductive Cancer
  
• Hormone Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
  adenocarcinoma of the prostate
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
  adult brain tumor
  
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
  Head and Neck Cancer
  
• Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
  disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00033254 - Active, not recruiting
  brain metastases
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
  Head and Neck Cancer
  
• Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082823 - Active, not recruiting
  Cancer
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00083213 - Active, not recruiting
  Cancer
  
• Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
  recurrent neuroblastoma
  
• Enzastaurin in Treating Patients With Recurrent Gliomas
  ClinicalTrials.gov Identifier: NCT00112788 - Active, not recruiting
  adult brain tumor
  
• Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
  Lung Cancer
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
  
• Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
  Head and Neck Cancer
  
• Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
  ClinicalTrials.gov Identifier: NCT00084513 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• The SILVER Study: Systolic Hypertension Interaction with Left Ventricular Remodeling
  ClinicalTrials.gov Identifier: NCT00045994 - Active, not recruiting
  Hypertension; Hypertrophy, Left Ventricular
  
• Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Bacterial Control in Partial Thickness Burns Using Silver-Containing Wound Dressings
  ClinicalTrials.gov Identifier: NCT00343824 - Recruiting
  Burn Wounds - Partial Thickness (2nd Degree)
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00028678 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00006734 - Active, not recruiting
  localized tumors of the Ewing's family
  
• Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
  
• Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
  adult glioblastoma
  
• Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
  Lymphoma
  
• Sorafenib in Treating Patients with Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
  Stage IV Melanoma
  
• GW786034 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Brief Strategic Family Therapy for Adolescent Drug Abusers - 1
  ClinicalTrials.gov Identifier: NCT00095303 - Active, not recruiting
  Behavior Therapy
  
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue
  
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
  Head and Neck Cancer; thorax and respiratory cancer
  
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
  ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
  adult soft tissue sarcoma
  
• Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
  Lymphoma
  
• Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
  renal clear cell carcinoma; Stage IV Renal Cell Cancer
  
• Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Tipifarnib in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00060125 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
  ClinicalTrials.gov Identifier: NCT00004074 - Active, not recruiting
  Cancer
  
• Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00012233 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer
  
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
  Cancer; oral complications of cancer and cancer therapy
  
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126490 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003478 - Active, not recruiting
  adult brain tumor
  
• ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054093 - Active, not recruiting
  Non-small cell lung cancer
  
• The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns
  ClinicalTrials.gov Identifier: NCT00156988 - Recruiting
  Burns
  
• Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00049296 - Active, not recruiting
  Cancer
  
• SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
  ClinicalTrials.gov Identifier: NCT00006247 - Active, not recruiting
  Brain Cancer
  
• Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003484 - Active, not recruiting
  Central Nervous System Tumor; Brain Tumor
  
• Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00054132 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
  ClinicalTrials.gov Identifier: NCT00005052 - Active, not recruiting
  stage II melanoma
  
• Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00027729 - Active, not recruiting
  recurrent colon cancer; recurrent rectal cancer
  
• Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00104988 - Active, not recruiting
  Stage IV Melanoma
  
• SU011248 in Treating Women With Metastatic Breast Cancer That Did Not Respond to Anthracycline or Taxane Chemotherapy
  ClinicalTrials.gov Identifier: NCT00095615 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00009776 - Active, not recruiting
  Burkitt's Lymphoma; Lymphocytic Lymphoma
  
• Thalidomide in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00015821 - Active, not recruiting
  Agnogenic Myeloid Metaplasia
  
• Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
  recurrent prostate cancer
  
• Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00047294 - Active, not recruiting
  Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00025233 - Active, not recruiting
  recurrent cervical cancer; cervical squamous cell carcinoma
  
• Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00064168 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Lymphocyte Therapy in Treating Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002589 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
  
• PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00053885 - Active, not recruiting
  advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma
  
• Comparison of Central Venous Catheters With Silver Nanoparticles Versus Conventional Catheters
  ClinicalTrials.gov Identifier: NCT00337714 - Recruiting
  Central Venous Catheter Related Infections
  
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00255762 - Active, not recruiting
  Recurrent Melanoma; Stage IV Melanoma
  
• Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00003857 - Active, not recruiting
  breast cancer in situ; intraductal breast carcinoma
  
• Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00031564 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016120 - Active, not recruiting
  recurrent prostate cancer